Cargando…
Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652473/ http://dx.doi.org/10.1186/2051-1426-3-S2-P438 |
_version_ | 1782401761602961408 |
---|---|
author | Karlsson-Parra, Alex Laurell, Anna Lönnemark, Maria Brekkan, Einar Wallgren, AnnaCarin Magnusson, Anders |
author_facet | Karlsson-Parra, Alex Laurell, Anna Lönnemark, Maria Brekkan, Einar Wallgren, AnnaCarin Magnusson, Anders |
author_sort | Karlsson-Parra, Alex |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4652473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46524732015-11-25 Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine Karlsson-Parra, Alex Laurell, Anna Lönnemark, Maria Brekkan, Einar Wallgren, AnnaCarin Magnusson, Anders J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652473/ http://dx.doi.org/10.1186/2051-1426-3-S2-P438 Text en Copyright © 2015 Karlsson-Parra et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Karlsson-Parra, Alex Laurell, Anna Lönnemark, Maria Brekkan, Einar Wallgren, AnnaCarin Magnusson, Anders Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine |
title | Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine |
title_full | Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine |
title_fullStr | Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine |
title_full_unstemmed | Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine |
title_short | Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine |
title_sort | long-term survival in unfavourable-risk mrcc patients after intratumoral administration of a cell-based allogeneic vaccine |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652473/ http://dx.doi.org/10.1186/2051-1426-3-S2-P438 |
work_keys_str_mv | AT karlssonparraalex longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine AT laurellanna longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine AT lonnemarkmaria longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine AT brekkaneinar longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine AT wallgrenannacarin longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine AT magnussonanders longtermsurvivalinunfavourableriskmrccpatientsafterintratumoraladministrationofacellbasedallogeneicvaccine |